Effective use of monoclonal antibodies for treatment of persistent COVID-19 infection in a patient on rituximab

As we are over a year into the COVID-19 pandemic, we have made many forward strides in therapeutics. These treatments, such as monoclonal antibodies, have help mitigate the detrimental and often fatal consequences of COVID-19. The current indication for the use of monoclonal antibodies is mild to mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Rabascall, Carlos X, Lou, Becky X, Navetta-Modrov, Brianne, Hahn, Stella S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336168/
https://www.ncbi.nlm.nih.gov/pubmed/34344651
http://dx.doi.org/10.1136/bcr-2021-243469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336168/
https://www.ncbi.nlm.nih.gov/pubmed/34344651
http://dx.doi.org/10.1136/bcr-2021-243469

Ejemplares similares